secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001193125-25-145742
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health extends $2.57M convertible note maturity to Jan 30, 2026; issues new warrants at $2.70 strike
--------------------------------------------------------------------------------

- Company entered Exchange Agreements with certain investors to replace ~$2.57M of 6% convertible notes originally due June 30, 2025; new maturity January 30, 2026.
- Replacement Notes convertible at $5.535/sh (non-insider) or $5.555/sh (insider); New Warrants exercisable at $2.70/sh, expire in 18 months.
- Insiders including CEO and board members participated in exchange, acquiring $492,012 principal of Replacement Notes and warrants for 177,138 shares.
- Prior to extension, five investors converted $0.866M of original notes into equity.
- Net proceeds from equity/debt financings or licensing above $8M must be used to repay Replacement Notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312525145742/0001193125-25-145742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312525145742/d885397d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-145742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer